Cryo-Cell International shareholders elect directors and approve auditor at annual meeting

Cryo-Cell International, Inc. (NYSE American:CCEL) held its annual meeting of stockholders on Tuesday. The company’s stock has been trading near its 52-week high of $5.20, with shares currently at $5.12. According to a statement based on a recent SEC filing, shareholders voted on several key matters, including the election of directors, the ratification of the company’s independent auditor, and an advisory vote on executive compensation.

Stockholders elected four directors to the board. David Portnoy received 6,474,964 votes in favor and 1,215,273 votes withheld. Harold Berger was elected with 7,121,908 votes in favor and 568,329 withheld. Mark Portnoy received 6,496,862 votes in favor and 1,193,375 withheld. Daniel Mizrahi was elected with 7,152,068 votes in favor and 538,169 withheld.

Shareholders also ratified the appointment of WIPFLI LLC as Cryo-Cell’s independent registered public accounting firm for the fiscal year ending November 30, 2026. The vote count was 7,578,019 in favor, 4,178 against, and 108,040 abstaining.

In addition, a non-binding advisory resolution regarding the compensation of the company’s named executive officers was approved, with 6,661,012 votes in favor, 1,028,359 against, and 866 abstentions.

A proposal authorizing proxies to vote on other business that might come before the meeting or any adjournments was also approved, with 6,513,018 votes in favor, 515,442 against, and 661,777 abstaining.

All information in this article is based on a press release statement filed with the Securities and Exchange Commission.